SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong
暂无分享,去创建一个
Samson S. Y. Wong | K. To | Lin-Lei Chen | W. Chan | R. W. Poon | V. Cheng | K. Yuen | K. Kok | C. Fong | Xiaojuan Zhang | Lu Lu | Brian Chun-Yuan Chan | J. Lam
[1] K. To,et al. Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong , 2022, Nature Communications.
[2] M. Ajelli,et al. Modeling transmission of SARS-CoV-2 Omicron in China , 2022, Nature Medicine.
[3] N. Garrett,et al. Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa , 2022, The New England journal of medicine.
[4] R. Iachan,et al. Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[5] O. Tsang,et al. Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines , 2022, eBioMedicine.
[6] K. To,et al. Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] S. Madhi,et al. South African Population Immunity and Severe Covid-19 with Omicron Variant , 2022, The New England journal of medicine.
[8] Gheyath K Nasrallah,et al. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection , 2022, The New England journal of medicine.
[9] K. To,et al. Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine , 2022, Emerging microbes & infections.
[10] OUP accepted manuscript , 2022, Clinical Infectious Diseases.
[11] O. Tsang,et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients , 2021, medRxiv.
[12] K. To,et al. Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 , 2021, The Lancet Regional Health - Western Pacific.
[13] Denis Sauré,et al. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study , 2021, The Lancet Infectious Diseases.
[14] K. To,et al. Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] K. To,et al. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein , 2020, mBio.